Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?

Sarcoidosis, an enigmatic disease with unknown etiology, is characterized by inflammation and the potential involvement of various organs, predominantly the lungs and intrathoracic lymph nodes. Non-caseating granulomas can resolve spontaneously in approximately 60% of cases within 2–3 years. However...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Karol Bączek, Wojciech Jerzy Piotrowski
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-08-01
Subjects:	sarcoidosis fibrosis antifibrotic agent pirfenidone nintedanib granuloma
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1445923/full